Our projects

Building research oversight capacity in Côte d’IvoireThe CECABI II project is developing the capacity of research ethics bodies in Côte d’Ivoire and enhancing coordination with its national...

Building regulatory capacity in West AfricaThe ECOWAS-RegECs project is helping to build regulatory and ethics capacity by simulating scientific advice and review of Lassa fever vaccine...

Understanding mpox virus infectionsThe MOVIE-TRACE project is clarifying two key aspects of mpox infections: the speed at which the virus is cleared from the body and its infectiousness.

Antibiotic-based combination therapy for severe malaria and bacterial bloodstream infectionsThe FACT project is developing an innovative treatment that targets both severe malaria and...

Field-testing moxidectin for river blindness controlThe EMINENCE project is exploring whether a newly developed drug, moxidectin, could accelerate the elimination of onchocerciasis (river...

Advancing monoclonal antibodies to treat HIV in infantsThe ENABLE project is assessing whether broadly neutralising antibodies could make the HIV virus undetectable in young infants.

Automating parasite egg detectionThe DIDIDI project is developing automated systems and AI tools to provide a more rapid assessment of parasitic worm burdens.

Protecting contacts of Bundibugyo patientsThe EBO-PEP 2026 project is assessing whether a licensed antiviral can prevent disease in individuals who have had close contact with patients with...

Standardised tracking of malaria and tuberculosis drug resistance The PANGenS project will introduce standardised approaches for identifying malaria and TB genetic variants associated with...

Accelerating vaccine development for neglected tropical diseasesThe EAVI project is establishing an international partnership to promote the clinical testing of vaccines against neglected...

Monitoring mpox vaccine activity in AfricaThe MpoxVax AFRIVAC project is closing key knowledge gaps on the performance of mpox vaccines in Central Africa.

Building capacity in new drug developmentThe PACoPPDeT project is developing a cohort of researchers with a deep understanding of all aspects of pharmaceutical product development.

Extending ivermectin use to young childrenThe IVM-KIDS project is developing a child-friendly formulation of ivermectin to ensure young children can benefit from this key drug for parasite...

Repurposing fusidic acid for onchocerciasis controlThe FAME project is assessing whether a repurposed antibiotic could improve control of onchocerciasis (river blindness).

TB prevention in people living with diabetesThe EDCTP2-funded PROTID project has received additional Global Health EDCTP3 funding, enabling it to complete its trial of preventive TB...

Protecting antibiotic potencyThe ASPIRE project is assessing whether improved infection prevention and control, coupled with more personalised antibiotic use, can reduce pressures driving...

Targeting vectors for infection prediction and controlThe IMPACTING project is collecting data on a host of insect vectors that spread infections to help better predict the risk of...

Rapid testing of urinary tract infectionsThe UTI-Diag project is exploring whether point-of-care tests could improve detection and management of urinary tract infections (UTIs) and reduce...

Enhancing data use for pandemic preparednessThe FORTRESS-SSA project is strengthening data-use capabilities within the public health workforce in sub-Saharan Africa, to promote the use of...

Stratifying care of hospitalised childrenThe PediSEP1 project is testing an approach to identify low-risk children who can be safely discharged from the hospital, allowing clinical attention...